Breaking News Instant updates and real-time market news.

CLSD

Clearside Biomedical

$12.15

0.05 (0.41%)

06:16
05/17/18
05/17
06:16
05/17/18
06:16

Clearside Biomedical management to meet with JMP Securities

Meeting to be held in New York on May 17 hosted by JMP Securities.

  • 17

    May

  • 21

    May

  • 23

    May

CLSD Clearside Biomedical
$12.15

0.05 (0.41%)

01/30/18
JPMS
01/30/18
NO CHANGE
Target $15
JPMS
Overweight
Clearside Biomedical could rally 150% on positive study, says JPMorgan
JPMorgan analyst Anupam Rama believes Clearside Biomedical shares could rally 70%-150% on positive a Peachtree study versus down 50%-70% on negative data. Top-line data from the Phase 3 trial of Clearside's suprachoroidal CLS-TA in non-infectious uveitis is expected in Q1, likely in the late-February / early-March timeframe, Rama tells investors in a research note. He believes the Phase 2 Dogwood data are overall de-risking and that Clearside's adjustments going from Phase 2 to Phase 3 increases the probability of success for CLS-TA to 75%. The analyst lowered his price target for Clearside Biomedical shares to $15 from $17 and keeps an Overweight rating on the name.
03/05/18
JMPS
03/05/18
NO CHANGE
Target $25
JMPS
Outperform
Clearside Biomedical price target raised to $25 from $21 at JMP Securities
JMP Securities analyst Donald Ellis increased his estimate of the probability of approval for CLS-TA to 80% from 70% after the treatment demonstrated statistically significant efficacy on both primary and secondary endpoints, as well as a "highly clinically relevant" 15-letter improvement from baseline, in a Phase 3 trial in non-infectious uveitis patients. He maintains an Outperform rating on the stock and raised his price target to $25 to reflect his view of the increased odds of success after the data.
03/06/18
NEED
03/06/18
NO CHANGE
Target $22
NEED
Buy
Clearside Biomedical price target raised to $22 from $18 at Needham
Needham analyst Serge Belanger raised his price target on Clearside Biomedical to $22 after the company's "CLS-TA met the primary endpoint and all key secondary endpoints in the phase 3 PEACHTREE trial. The analyst also keeps his Buy rating, adding that the positive dataset allows Clearside Biomedical to proceed with an NDA filing for a uveitis indication in Q4 of this year while de-risking the overall program going into related data readouts later this year.
05/11/18
WEDB
05/11/18
NO CHANGE
WEDB
Clearside valuation attractive ahead of potential catalysts, says Wedbush
Wedbush analyst Liana Moussatos maintained an Outperform rating and $29 price target on Clearside Biomedical shares, saying the current valuation is attractive in front of multiple potential catalysts, including the Phase 2 TYBEE data for suprachoroidal CLS-TA in DME in Q2, preliminary data from the Phase 3 SAPPHIRE trial for MERVO in Q4, and NDA submission for ME-NIU to the FDA in Q4.

TODAY'S FREE FLY STORIES

DAC

Danaos

$1.60

0.05 (3.23%)

16:52
09/24/18
09/24
16:52
09/24/18
16:52
Earnings
Danaos reports Q2 EPS 27c, one estimate 23c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

AWK

American Water

$87.80

-0.8 (-0.90%)

16:46
09/24/18
09/24
16:46
09/24/18
16:46
Hot Stocks
American Water to spend $2M to upgrade water main in Missouri »

Missouri American Water…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

COLD

Americold Realty Trust

$25.25

-0.09 (-0.36%)

16:45
09/24/18
09/24
16:45
09/24/18
16:45
Hot Stocks
Breaking Hot Stocks news story on Americold Realty Trust »

Senator Investment Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRNB

Principia Biopharma

$27.34

0.24 (0.89%)

16:45
09/24/18
09/24
16:45
09/24/18
16:45
Hot Stocks
Breaking Hot Stocks news story on Principia Biopharma »

Cormorant Asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DCPH

Deciphera

$39.80

0.78 (2.00%)

16:42
09/24/18
09/24
16:42
09/24/18
16:42
Initiation
Deciphera initiated  »

Deciphera initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 27

    Nov

BJ

BJ's Wholesale

$28.47

-0.68 (-2.33%)

16:42
09/24/18
09/24
16:42
09/24/18
16:42
Syndicate
BJ's Wholesale files to sell 28M shares of common stock for holders »

BofA Merrill Lynch,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

BPMC

Blueprint Medicines

$71.56

1.8 (2.58%)

16:41
09/24/18
09/24
16:41
09/24/18
16:41
Initiation
Blueprint Medicines initiated  »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGEN

Seattle Genetics

$78.57

0.53 (0.68%)

16:41
09/24/18
09/24
16:41
09/24/18
16:41
Initiation
Seattle Genetics initiated  »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOXO

Loxo Oncology

$163.07

3.91 (2.46%)

16:40
09/24/18
09/24
16:40
09/24/18
16:40
Initiation
Loxo Oncology initiated  »

Loxo Oncology initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 27

    Nov

INCY

Incyte

$66.48

-0.11 (-0.17%)

16:40
09/24/18
09/24
16:40
09/24/18
16:40
Initiation
Incyte initiated  »

Incyte initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AGIO

Agios Pharmaceuticals

$75.39

1.84 (2.50%)

16:40
09/24/18
09/24
16:40
09/24/18
16:40
Initiation
Agios Pharmaceuticals initiated  »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMLR

Semler Scientific

$0.00

(0.00%)

16:40
09/24/18
09/24
16:40
09/24/18
16:40
Hot Stocks
Breaking Hot Stocks news story on Semler Scientific »

Park West Asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLVS

Clovis

$32.63

0.22 (0.68%)

16:39
09/24/18
09/24
16:39
09/24/18
16:39
Initiation
Clovis initiated  »

Clovis initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$291.09

-0.94 (-0.32%)

16:39
09/24/18
09/24
16:39
09/24/18
16:39
Periodicals
Trump inks revised trade pact with South Korea, CNBC says »

U.S. president Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$291.09

-0.94 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$36.41

-1.27 (-3.37%)

16:39
09/24/18
09/24
16:39
09/24/18
16:39
Initiation
Tesaro initiated  »

Tesaro initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

BGNE

BeiGene

$166.12

2.15 (1.31%)

16:38
09/24/18
09/24
16:38
09/24/18
16:38
Initiation
BeiGene initiated  »

BeiGene initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 27

    Nov

BW

Babcock & Wilcox

$1.03

0.005 (0.49%)

16:38
09/24/18
09/24
16:38
09/24/18
16:38
Hot Stocks
Babcock & Wilcox to relocate Headquarters to Ohio »

Babcock & Wilcox…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAGX

Jaguar Health

$0.63

-0.022 (-3.37%)

16:37
09/24/18
09/24
16:37
09/24/18
16:37
Hot Stocks
Jaguar Health, Knight Therapeutics announce strategic partnership »

Knight Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HST

Host Hotels

$20.89

-0.23 (-1.09%)

, VNO

Vornado

$73.52

-1.58 (-2.10%)

16:36
09/24/18
09/24
16:36
09/24/18
16:36
Hot Stocks
Host Hotels sells New York Marriott Marquis Retail to Vornado for $442M »

Host Hotels & Resorts…

HST

Host Hotels

$20.89

-0.23 (-1.09%)

VNO

Vornado

$73.52

-1.58 (-2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CWEN

Clearway Energy

$19.85

-0.1 (-0.50%)

16:33
09/24/18
09/24
16:33
09/24/18
16:33
Syndicate
Clearway Energy announces offering of 3.92M shares of Class C common stock »

Clearway Energy …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KIRK

Kirkland's

$9.30

-0.02 (-0.21%)

16:33
09/24/18
09/24
16:33
09/24/18
16:33
Hot Stocks
Kirkland's announces new $10M share repurchase program »

Kirkland's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUM

Summit Materials

$18.76

-0.285 (-1.50%)

16:32
09/24/18
09/24
16:32
09/24/18
16:32
Hot Stocks
Summit Materials sells GJP to Ferguson Waterworks, terms not stated »

Summit Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KIRK

Kirkland's

$9.30

-0.02 (-0.21%)

16:32
09/24/18
09/24
16:32
09/24/18
16:32
Hot Stocks
Kirkland's names Steve Woodward as CEO, Mike Cairnes as COO »

Kirkland's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WRE

Washington REIT

$30.60

-0.32 (-1.03%)

16:32
09/24/18
09/24
16:32
09/24/18
16:32
Periodicals
Washington REIT explores sale of retail portfolio, Bloomberg reports »

Washington REIT is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$291.09

-0.94 (-0.32%)

16:31
09/24/18
09/24
16:31
09/24/18
16:31
Periodicals
Trump says second meeting with Kim Jong Un likely 'quite soon,' AP says »

U.S. president Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$291.09

-0.94 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.